WP
BVS icon

Woodline Partners’s Bioventus BVS Stock Holding History

Woodline Partners’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-205,594
Closed -$3.14M – 598
2021
Q1 		$3.14M Buy
+205,594
New +$2.93M 0.07% 242

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Woodline Partners's BVS Position: Q2 2021 in Review

Woodline Partners sold out of Bioventus (BVS) in Q2 2021, closing a stake of 205,594 shares — an estimated $3.14M sold.

Woodline Partners first reported a position in BVS in Q1 2021 and held it in 1 quarter. The position peaked at $3.14M in Q1 2021. 53 funds tracked by Wall St. Rank hold BVS as of Q2 2021.

  • Woodline Partners reported no remaining Bioventus position as of Q2 2021 after selling out during the quarter.
  • Woodline Partners sold 205,594 Bioventus shares in Q2 2021, an estimated $3.14M.
  • Woodline Partners first reported a position in Bioventus in Q1 2021 and held it in 1 quarter.
  • Woodline Partners's Bioventus position peaked at $3.14M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Bioventus as of Q2 2021.

Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.